Rensselaer Researchers have Developed an Approach that Predicts Protein Separation Behavior
News Sep 07, 2005
Researchers at Rensselaer Polytechnic Institute have announced that they have developed a method to predict protein separation behavior directly from protein structure.
According to Researchers, this multi-scale protein modeling approach may reduce the time it takes to bring pharmaceuticals to market and may have significant implications for an array of biotechnology applications, including bioprocessing, drug discovery, and proteomics, the study of protein structure and function.
“Predictive modeling is a new approach to drug discovery that takes information from lab analysis and concentrates it in predictive models that may be evaluated on a computer,” said Curt M. Breneman, professor of chemistry and chemical biology at Rensselaer.
“The ability to predict the separation behavior of a particular protein directly from its structure has considerable implications for biotechnology processes,” said Steven Cramer, professor of chemical and biological engineering at Rensselaer.
He adds, “The research results thus far indicate that this modeling approach can be used to determine protein behavior for use in bioseparation applications, such as the protein purification methods used in drug discovery. This could potentially reduce the development time required to bring biopharmaceuticals to market.”
The modeling technique is based on methods previously developed by Breneman's group for rapidly predicting the efficacy and side effects of small drug-like molecules. The model predicted the amount of a protein that binds to a material under a range of conditions by using molecular information obtained from the protein structure.
These predicted adsorption isotherm parameters then replicated experimental results by predicting the actual separation profile of proteins in chromatographic columns. Chromatography techniques are used to identify and purify molecules, in this case, particular proteins.
“We intend to test the model against more complicated protein structures as part of its further development,” said Breneman. He adds, “The outcome of this work will yield fundamental information about the complex relationship between a protein’s structural features and its chemical binding properties, and also aid in evaluating its potential biomedical applications.”
The research findings are reported in the Aug. 16 issue of Proceedings of the National Academy of Sciences in a paper titled "A Priori Prediction of Adsorption Isotherm Parameters and Chromatographic Behavior in Ion-Exchange Systems."
The researchers' computational model uses a combination of molecular-level quantitative structure-property relationship models with macroscopic steric mass action isotherm models and support vector machine regression computations.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.
15th International Conference and Exhibition on Metabolomics & Systems
Apr 29 - Apr 30, 2019